# Boehringer Ingelheim Venture Fund's Biotech Investments: 29 Startups in Its Portfolio (2026) > The 29 Biotech startups Boehringer Ingelheim Venture Fund has backed, by stage: $856M raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/boehringer-ingelheim-venture-fund-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series A 11 - [DiogenX](https://millionrounds.com/company/diogenx) - [Asgard Therapeutics](https://millionrounds.com/company/asgard-therapeutics) - [*AT* Aelin Therapeutics](https://millionrounds.com/company/aelin-therapeutics) - [Libra Therapeutics](https://millionrounds.com/company/libra-therapeutics) - [Actym Therapeutics, Inc.](https://millionrounds.com/company/actym-therapeutics-inc) - [ArmaGen Technologies](https://millionrounds.com/company/armagen-technologies) - [*R* Rigontec](https://millionrounds.com/company/rigontec) - [Dopavision](https://millionrounds.com/company/dopavision) - [*AT* Abalos Technologies](https://millionrounds.com/company/abalos-technologies) - [Sentien Biotechnologies](https://millionrounds.com/company/sentien-biotechnologies) - [Vira Therapeutics](https://millionrounds.com/company/vira-therapeutics) ## Pre-seed and seed 8 - [SRTD Biotech](https://millionrounds.com/company/srtd-biotech) - [Cloverleaf Bio](https://millionrounds.com/company/cloverleaf-bio) - [Tacalyx](https://millionrounds.com/company/tacalyx) - [EvlaBio](https://millionrounds.com/company/evlabio) - [Delonix Bioworks](https://millionrounds.com/company/delonix-bioworks) - [TECregen](https://millionrounds.com/company/tecregen) - [STRM.BIO](https://millionrounds.com/company/strm-bio) - [Rinri Therapeutics](https://millionrounds.com/company/rinri-therapeutics) ## Series B 4 - [ImCheck Therapeutics](https://millionrounds.com/company/imcheck-therapeutics) - [OncoMyx Therapeutics](https://millionrounds.com/company/oncomyx-therapeutics) - [etherna immunotherapies](https://millionrounds.com/company/etherna-immunotherapies) - [*AT* Amal Therapeutics](https://millionrounds.com/company/amal-therapeutics) ## Stage not reported 3 - [HepaRegeniX](https://millionrounds.com/company/heparegenix) - [smartbax](https://millionrounds.com/company/smartbax) - [Glox Therapeutics](https://millionrounds.com/company/glox-therapeutics) ## Series C and later 3 - [*PB* Promethera Biosciences](https://millionrounds.com/company/promethera-biosciences) - [STAT-Dx](https://millionrounds.com/company/stat-dx) - [NBE-Therapeutics](https://millionrounds.com/company/nbe-therapeutics) ## Segment by segment ### Series A 11 startups · $242M raised - [**DiogenX**](https://millionrounds.com/company/diogenx) DiogenX is a preclinical-stage biotechnology company founded in 2020, based in Marseille, France, with research laboratories in Nice. France $37M - [**Asgard Therapeutics**](https://millionrounds.com/company/asgard-therapeutics) Asgard Therapeutics is a privately held biotech company based in Lund, Sweden, founded in 2018 as a spin-off from Lund University. Sweden $33M - [*AT* **Aelin Therapeutics**](https://millionrounds.com/company/aelin-therapeutics) Aelin engages in the research and development of biotherapeutics that utilizes protein aggregation to induce the functional knockd Belgium $32M - [**Libra Therapeutics**](https://millionrounds.com/company/libra-therapeutics) Libra Therapeutics is a biotechnology company. - $29M - [**Actym Therapeutics, Inc.**](https://millionrounds.com/company/actym-therapeutics-inc) Actym Therapeutics, Inc. United States $26M - [**ArmaGen Technologies**](https://millionrounds.com/company/armagen-technologies) ArmaGen is focused on developing technologies for siRNA delivery across the blood-brain barrier. United States $25M - [*R* **Rigontec**](https://millionrounds.com/company/rigontec) Germany $17M - [**Dopavision**](https://millionrounds.com/company/dopavision) Dopavision is a digital health company based in Berlin, founded in 2017. Germany $14M ### Pre-seed and seed 8 startups · $162M raised - [**SRTD Biotech**](https://millionrounds.com/company/srtd-biotech) SRTD Biotech GmbH is a biotechnology company based in Jülich, Germany, specializing in the development of RNA-based therapeutics. Germany $35M - [**Cloverleaf Bio**](https://millionrounds.com/company/cloverleaf-bio) Cloverleaf Bio is a biotechnology company based in New Haven, Connecticut, founded in 2023. United States $33M - [**Tacalyx**](https://millionrounds.com/company/tacalyx) Tacalyx is a biotech company focused on the discovery and development of novel anti-TACA Germany $28M - [**EvlaBio**](https://millionrounds.com/company/evlabio) EvlaBio AG is a life science startup based in Zürich, Switzerland, founded in 2022. Switzerland $25M - [**Delonix Bioworks**](https://millionrounds.com/company/delonix-bioworks) Delonix Bioworks is a biotech company based in Shanghai, China, specializing in the development of genetically engineered bacterial vaccines. China $14M - [**TECregen**](https://millionrounds.com/company/tecregen) TECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses. Switzerland $13M - [**STRM.BIO**](https://millionrounds.com/company/strm-bio) STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient and practical manner. United States $8.0M - [**Rinri Therapeutics**](https://millionrounds.com/company/rinri-therapeutics) Rinri Therapeutics is a biotechnology company developing a novel cell-based therapy. United Kingdom $6.4M ### Series B 4 startups · $244M raised - [**ImCheck Therapeutics**](https://millionrounds.com/company/imcheck-therapeutics) ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules. France $97M - [**OncoMyx Therapeutics**](https://millionrounds.com/company/oncomyx-therapeutics) OncoMyx Therapeutics is a biotechnology company based in Phoenix, Arizona, founded in 2018. United States $75M - [**etherna immunotherapies**](https://millionrounds.com/company/etherna-immunotherapies) eTheRNA develops immunotherapies that target the fundamental role of dendritic cells in the human immune system. Belgium $39M - [*AT* **Amal Therapeutics**](https://millionrounds.com/company/amal-therapeutics) Amal Therapeutics SA is a privately held Swiss/German biotech start-up company and spin-off from the University of Geneva. Switzerland $33M ### Stage not reported 3 startups · $40M raised - [**HepaRegeniX**](https://millionrounds.com/company/heparegenix) HepaRegeniX is developing drugs for treating acute and chronic liver diseases. Germany $34M - [**smartbax**](https://millionrounds.com/company/smartbax) smartbax GmbH is a biotechnology startup based in Munich, Germany, founded in 2021 as a spin-off from the Technical University of Munich. Germany $5.5M - [**Glox Therapeutics**](https://millionrounds.com/company/glox-therapeutics) Glox Therapeutics creates precision antibiotics through the use of engineered protein bacteriocins. United Kingdom $617K ### Series C and later 3 startups · $168M raised - [*PB* **Promethera Biosciences**](https://millionrounds.com/company/promethera-biosciences) Belgium $115M - [**STAT-Dx**](https://millionrounds.com/company/stat-dx) STAT-Dx is focused on the development of near-patient testing products for healthcare professionals. - $29M - [**NBE-Therapeutics**](https://millionrounds.com/company/nbe-therapeutics) NBE-Therapeutics is a biotech company that develops oncology treatments for cancer patients. Switzerland $25M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Boehringer Ingelheim Venture Fund as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Wayra's IT Services portfolio** 57 startups · $38M](https://millionrounds.com/portfolio-maps/wayra-it-services-portfolio)[Sector portfolio **Wayra's Internet portfolio** 26 startups · $13M](https://millionrounds.com/portfolio-maps/wayra-internet-portfolio)[Sector portfolio **Wayra's AI portfolio** 25 startups · $246M](https://millionrounds.com/portfolio-maps/wayra-ai-portfolio)[Sector portfolio **Wayra's Fintech portfolio** 22 startups · $287M](https://millionrounds.com/portfolio-maps/wayra-fintech-portfolio)[Sector portfolio **Wayra's Consumer Apps portfolio** 22 startups · $8.1M](https://millionrounds.com/portfolio-maps/wayra-consumer-apps-portfolio)[Sector portfolio **Wayra's Advertising & Adtech portfolio** 18 startups · $8.4M](https://millionrounds.com/portfolio-maps/wayra-advertising-adtech-portfolio) ## Raising from investors like Boehringer Ingelheim Venture Fund? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)